A federal judge in southern Illinois has dismissed a lawsuit that a small health provider filed against BD (NYSE:BDX) that claimed that the medtech giant engaged in antitrust behavior with distributors Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK). Judge Nancy J. Rosenstengel had previously dismissed the lawsuit by Marion Diagnostic Center and Marion HealthCare, […]
BD
BD partners with ImageMover for COVID-19 test mobile app
Becton Dickinson (NYSE:BDX) announced today that it entered into an agreement with ImageMover to offer a mobile app for COVID-19 testing. Franklin Lakes, N.J.-based Becton Dickinson’s agreement enables the ImageMover software platform to simplify medical data collection and management through a companion mobile app for SARS-CoV-2 antigen testing performed on the BD Veritor Plus system, […]
MedTech 100 roundup: Industry sees largest fall since October
The medtech industry’s hot start to 2021 has finally come to a full halt after stocks fell harder than they had in more than four months. MassDevice‘s MedTech 100 index ended the week (March 5) at 103.3 points, marking a -3.1% dip from the 106.65-point mark set one week before (Feb. 26). In less than a […]
Becton Dickinson acquires smart medication device maker GSL Solutions
Becton Dickinson (NYSE:BDX) announced today that it acquired smart medication device developer GSL solutions for an undisclosed amount. Franklin Lakes, N.J.-based BD said in a news release that GSL Solutions develops devices for storing and tracking controlled substances, as well as patient-specific medications that improve the security, efficiency and compliance of medication storage. Additionally, the company […]
BD, Scanwell Health collaborating on smartphone-enabled, home COVID-19 rapid test
Becton Dickinson (NYSE:BDX) announced today that it is collaborating with Scanwell Health to create an at-home rapid COVID-19 test. Scanwell Health, a developer of smartphone-enabled at-home medical tests, will offer its mobile app to pair with a BD antigen test for SARS-CoV-2, the virus causing COVID-19, according to a news release. As part of the collaboration, […]
FDA panel votes against BD Lutonix drug-coated balloon for below-the-knee
An FDA advisory panel voted against a favorable recommendation for BD‘s Lutonix catheter-based, drug-coated balloon for use below the knee. The FDA’s Circulatory System Devices Advisory Panel yesterday voted 15-to-2 in favor of the issue of safety when Lutonix is used as intended and voted 15-to-2 against the issue of a reasonable assurance of effectiveness. The […]
BD wins Frost & Sullivan innovation award for Intevia autoinjector
Frost & Sullivan announced today that it recognizes Becton Dickinson (NYSE:BDX) with a 2020 Global Technology Innovation Award. BD received the award for its Intevia autoinjector, which, as part of the company’s differentiated self-injection systems portfolio, facilitates high-viscosity biologics delivery for treating chronic diseases, according to a news release. Get the full story at our sister site, […]
BD secures EUA, CE Mark for molecular test for both COVID-19 and flu
BD today said it received FDA emergency use authorization and CE mar approval for its rapid molecular diagnostic test for both SARS-CoV-2 and Influenza A+B test. The test can return results in two to three hours and the FDA EUA includes updated information in the test’s instructions for use that addresses variants of the SARS-CoV-2 […]
MedTech 100 roundup: Index hits another all-time high
The beginning of February brought yet another peak for medtech stocks. MassDevice‘s MedTech 100 index ended the week (Feb. 5) at 108.23 points, marking a 4% rise from the 104.05-point mark set at the end of the previous week (Jan. 29). The final mark for the week sets an all-time best for the index, which had […]
Becton Dickinson beats The Street, raises 2021 guidance
Becton Dickinson (NYSE:BDX) shares dipped slightly despite first-quarter results that came in well above the consensus forecast. The Franklin Lakes, N.J.-based company posted profits of $981 million, or $3.35 per share, on sales of $5.3 billion for the three months ended Dec. 31, 2020, tripling its bottom-line on sales growth of 25.8%. Adjusted to exclude one-time […]
BD CEO Polen to also serve as board chair
Tom Polen, the CEO of Becton Dickinson (NYSE:BDX), will also serve as BD’s board chair effective April 28, the company said today. Polen takes over the board chair slot from former CEO Vincent A. Forlenza, who will retire at that time. Polen, 47, has held the corner office at BD since January 2020. He joined […]